GGrantIndex
Sort

64,565 grants matching drug discovery

Natural Products Discovery and Characterization Through Network Collaborations

$1,334,583
Kirk Gustafson · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Discovery And Functional Genomics Of Environmental Response Genes

$1,334,405
Douglas Bell · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

RP1: Targeting Beclin 1 complexes for broad-spectrum anti-infective therapeutics

$1,334,248
Tiffany Anne Reese · Ut Southwestern Medical Center · U19 · FY2023 · AI

Brewing anti-toxin drugs using probiotic yeast

$1,333,682
Nathan C. Crook · North Carolina State University Raleigh · DP2 · FY2023 · AT

Discovery to Implementation & Back: Research Translation for the HIV/SU Epidemic

$1,332,543
Sherry Deren · New York University · P30 · FY2016 · DA

Shared Resource Management

$1,332,221
James V Degregori · University Of Colorado Denver · P30 · FY2025 · CA

Virus and Host Directed Immunotherapies for Cure in SHIV-infected Infant Macaques

$1,332,155
Ann M Chahroudi · Emory University · R01 · FY2025 · AI

Preclinical Development of HIV-1 Vif Antagonists

$1,331,690
Mario Stevenson · Univ Of Massachusetts Med Sch Worcester · U19 · FY2009 · MH

Building an Implantable Artificial Kidney

$1,331,543
Shuvo Roy · University Of California, San Francisco · U01 · FY2015 · EB

Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas

$1,331,513
Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2013 · HL

International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis

$1,331,243
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Combinatorial Chemistry and Cancer Target

$1,330,981
Scripps Research Institute · P01 · FY2005 · CA

Creating a predictive vascular system for early development

$1,330,814
Brett R Blackman · Hemoshear Therapeutics, Llc · R44 · FY2013 · HL

Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome And Other Immunoregulatory Disorders

$1,330,618
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Molecular Definition of Brain Circuits Controlling Addiction

$1,330,506
Nathaniel Heintz · Rockefeller University · P30 · FY2014 · DA

Molecular Definition of Brain Circuits Controlling Addiction

$1,330,506
Nathaniel Heintz · Rockefeller University · P30 · FY2017 · DA

Engineered human intestinal organoids: a modular system to model enteric disease

$1,330,188
Vincent B Young · University Of Michigan At Ann Arbor · U19 · FY2018 · AI

Molecular Pathology Research for Cancer Diagnostics and Biomarkers

$1,330,042
Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA

Development Of New Chemotherapeutics For Tuberculosis

$1,329,738
Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

High Throughput Screening for Ligands for Seven Transmembrane-spanning Receptors

$1,329,198
Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

NEW DRUG TARGETS FOR APOPTOSIS

$1,329,187
University Of Arizona · P01 · FY2002 · CA

Interventional approaches for restoring vision

$1,328,522
Anand Swaroop · National Eye Institute · ZIA · FY2013 · EY

Functional Selectivity: A Novel approach for CNS Drug Discovery

$1,328,482
Bryan L Roth · Univ Of North Carolina Chapel Hill · U19 · FY2007 · MH

PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial

$1,327,969
Roberta Diaz Brinton · University Of Arizona · R01 · FY2024 · AG

Development and Preclinical Applications of Pancreatic Adenocarcinoma Models

$1,327,446
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA